-transparent.png){kind=logo}
Recombinant Escherichia coli-derived gamma-interferon has been shown to stimulate synthesis of the second component of complement (C2), factor B and C1 inhibitor, but to inhibit synthesis of the third component (C3). alpha- and beta-interferons stimulate synthesis of factor B and C3 inhibitor, inhibit C5 synthesis but do not alter synthesis of C2. alpha- and beta-interferons act synergistically with gamma-interferon to enhance both factor B and C1-inhibitor synthesis.
Related Publications
A O Hamilton, and
L Jones, and
L Morrison, and
K Whaley
June 1990,
The Biochemical journal,
A O Hamilton, and
L Jones, and
L Morrison, and
K Whaley
April 1989,
Clinical and experimental immunology,
A O Hamilton, and
L Jones, and
L Morrison, and
K Whaley
September 1981,
Immunology,
A O Hamilton, and
L Jones, and
L Morrison, and
K Whaley
December 1980,
Clinical and experimental immunology,
A O Hamilton, and
L Jones, and
L Morrison, and
K Whaley
July 2000,
Clinical and experimental immunology,
A O Hamilton, and
L Jones, and
L Morrison, and
K Whaley
January 1991,
Cancer treatment and research,
A O Hamilton, and
L Jones, and
L Morrison, and
K Whaley
January 1983,
Springer seminars in immunopathology,
A O Hamilton, and
L Jones, and
L Morrison, and
K Whaley
May 2020,
Nature communications,
A O Hamilton, and
L Jones, and
L Morrison, and
K Whaley
January 1984,
Complement (Basel, Switzerland),
A O Hamilton, and
L Jones, and
L Morrison, and
K Whaley
July 1997,
Russian journal of immunology : RJI : official journal of Russian Society of Immunology,
